Susceptibility of Gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 3031-3034

  Hoban, Daryl J ^a   Bouchillon, Samuel K ^a   Hawser, Stephen P ^b   Badal, Robert E ^a   LaBombardi, Vincent J ^c   DiPersio, Joseph ^d  

^a Division of Microbiology   (United States)

^b International Health Management Associates Europe Sàrl   (Switzerland)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d AKRON CITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; BETA LACTAM;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CITROBACTER FREUNDII; DRUG MONITORING; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; TREND STUDY; UNITED STATES; ABDOMEN; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY;

ABDOMEN; AMIKACIN; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS;

EID: 77953738803     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01808-09     Document Type: Article

References (14)

1. Badal, R., S. Hawser, S. Bouchillon, A. Johnson, M. Hackel, and D. Hoban. 2009. Evaluation of EUCAST and CLSI cephalosporin breakpoints vs. ESBL+ and ESBL- E. coli, K. pneumoniae and K. oxytoca in the SMART study. Poster E-204 presented at the 49th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA. American Society for Microbiology, Washington, DC.
2. Baquero, F., P.-R. Hsueh, D. L. Paterson, F. Rossi, G. V. Bochicchio, G. Gallagher, K. Lantz, J. B. Villasenor, K. McCarroll, M. A. Abramson, and J. W. Chow. 2009. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg. Infect. 10:99-104.
3. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement, document M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement, document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Hawser, S. P., S. K. Bouchillon, D. J. Hoban, R. E. Badal, P.-R. Hsueh, and D. L. Paterson. 2009. Emergence of high levels of extended-spectrum-β- lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007. Antimicrob. Agents Chemother. 53:3280-3284.
6. Hawser, S. P., S. K. Bouchillon, D. J. Hoban, and R. E. Badal. 2009. In vitro susceptibilities of aerobic and facultative anaerobic gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. Int. J. Antimicrob. Agents 34:585-588.
7. Hirakata, Y., J. Matsuda, Y. Miyazaki, S. Kamihira, S. Kawakami, Y. Miyazawa, Y. Ono, N. Nakazaki, Y. Hirata, M. Inoue, J. D. Turnidge, J. M. Bell, R. N. Jones, S. Kohno, and the SENTRY Asia-Pacific Participants. 2005. Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn. Microbiol. Infect. Dis. 52:323-329.
8. Hoban, D. J., S. K. Bouchillon, S. P. Hawser, and R. E. Badal. 2010. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn. Microbiol. Infect. Dis. 66:78-86.
9. Lewis, J. S., II, M. Herrara, B. Wickes, J. E. Patterson, and J. H. Jorgensen. 2007. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015-4021.
10. Montravers, P., A. Lepape, L. Dubreuil, R. Gauzit, Y. Pean, D. Benchimol, and H. Dupont. 2009. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J. Antimicrob. Chemother. 63:785-794.
11. Nicolas-Chanoine, M.-H., V. Jarlier, and La Collégialé de Bactériologie-Virologie-Hygiène Hospitalière de l'Assistance Publique, Hôpitaux de Paris, France. 2008. Extended-spectrum β-lactamases in long-term-care facilities. Clin. Microbiol. Infect. 14(Suppl. 1):111-116.
12. Paterson, D. L., F. Rossi, F. Baquero, P.-R. Hsueh, G. L. Woods, V. Satishchandran, T. A. Snyder, C. M. Harvey, H. Teppler, M. J. DiNubile, and J. W. Chow. 2005. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J. Antimicrob. Chemother. 55:965-973.
13. Rossi, F., F. Baquero, P.-R. Hsueh, D. L. Paterson, G. V. Bochicchio, T. A. Snyder, V. Satishchandran, K. McCarroll, M. J. DiNubile, and J. W. Chow. 2006. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J. Antimicrob. Chemother. 58:205-210.
14. Solomkin, J. S., J. E. Mazuski, E. J. Baron, R. G. Sawyer, A. B. Nathens, J. T. DiPiro, T. Buchman, E. P. Dellinger, J. Jernigan, S. Gorbach, A. W. Chow, and J. Bartlett. 2003. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin. Infect. Dis. 37:997-1005.